United Therapeutics (UTHR) Shares Outstanding (2009 - 2026)

United Therapeutics has reported Shares Outstanding (Entity) for 18 years, with the latest figure at $43.5 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) fell 3.12% year-over-year to $43.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $43.5 million (down 3.12% YoY) and the FY2025 annual result came in at $44.3 million, down 1.99% from the prior year.
• Shares Outstanding (Entity) declined to $43.5 million in Q1 2026 per UTHR's latest filing, from $44.3 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $47.0 million in Q1 2024 and troughed at $43.5 million in Q1 2026.
• A 5-year average of $45.4 million and a median of $45.2 million in 2022 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Entity) gained 3.3% in 2023, then slipped 5.33% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $45.5 million in 2022, then grew by 2.86% to $46.8 million in 2023, then fell by 3.42% to $45.2 million in 2024, then declined by 1.99% to $44.3 million in 2025, then fell by 1.81% to $43.5 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $43.5 million, $44.3 million, and $43.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.